药物与高血压相关的药物:通过不成比例性分析进行的回顾性药监测研究的结果
1Pharmacology & Therapeutics, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Bahrain skannandr@gmail.com.
European journal of hospital pharmacy : science and practice
|January 9, 2025
概括
这项研究使用美国食品和药物管理局的AERS数据库识别了与快速耐药性 (tachyphylaxis) 相关的药物. 这些发现突显了风险,并需要进一步研究药物耐受性机制.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 药物耐药性 (Tachyphylaxis) 是在重复服用药物后药物耐药性迅速出现的情况.
- 了解药物诱导的高血压症对于患者的安全和有效治疗至关重要.
研究的目的:
- 用USFDA AERS数据库的不成比例性分析来识别与太基肌病显著相关的药物.
- 为了检测与药物相关的高血压症的安全信号.
主要方法:
- 为了检测安全信号,使用了不成比例分析,包括频率和贝叶斯方法.
- 分析了来自USFDA AERS数据库 (2004-2024) 的29,153,222份报告,其中242份报告涉及高血压症.
主要成果:
- 经过充分记录的药物类别,如皮质类固醇,阿片类药物和抗生素药物证实了太基法力学.
- 观察到与普罗波福尔,西萨特拉库里,牛炭胺和卡伯戈林的新兴关联,需要进一步研究.
- 显著的百分比的tachyphylaxis病例导致住院 (16.9%),残疾 (5%),和死亡 (2.5%).
结论:
- 该研究确定了关键的药物类别和特定的药物与tachyphylaxis相关.
- 局限性包括潜在的报告不足以及不良事件报告中缺乏详细的临床背景.
- 未来的研究应该探索太基菲拉克西的机制,并为长期治疗制定缓解策略.
更多相关视频
相关概念视频
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Pharmacovigilance
771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
80
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
80
Analysis of Population Pharmacokinetic Data
222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222
Nonlinear Pharmacokinetics: Overview
264
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
264
Time Course of Drug Effect
1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K


